Characteristics | Total (n = 214) | Definite-TB (n = 34) | Unconfirmed-TB (n = 86) | Unlikely-TB (n = 94) | p-value |
---|---|---|---|---|---|
Age in months, median (IQR) | 36 (19–66) | 56 (23–109) | 34 (15–63) | 32 (17–63) | 0.003 |
Sex: female, n (%) | 109 (51) | 14 (41) | 45 (52) | 50 (53) | 0.03 |
HIV infection, n (%) | 27 (13) | 7 (21) | 13 (15) | 7 (7) | 0.14 |
HIV WHO clinical staging, n (%) | |||||
 Stage 1 | 0 | 0 | 0 | 0 | - |
 Stage 2 | 0 | 0 | 0 | 0 | - |
 Stage 3 | 21 (10) | 5 (15) | 10 (12) | 6 (6) | 0.36 |
 Stage 4 | 6 (3) | 2 (6) | 3 (35) | 1 (1) | 0.48 |
Smoking: yes, n (%) | 29 (14) | 5 (15) | 12 (14) | 12 (13) | 0.56 |
Night sweats: yes, n (%) | 118 (55) | 15 (44) | 57 (66) | 46 (49) | 0.61 |
Fever: yes, n (%) | 102 (48) | 13 (38) | 52 (60) | 37 (39) | 0.19 |
Malaise: yes, n (%) | 62 (29) | 14 (41) | 30 (35) | 18 (19) | 0.88 |
Cough: yes, n (%) | 165 (77) | 27 (79) | 67 (78) | 71 (76) | 0.61 |
Appetite loss: yes, n (%) | 110 (51) | 18 (53) | 43 (50) | 48 (51) | 0.69 |
Weight loss: yes, n (%) | 133 (62) | 23 (68) | 63 (73) | 47 (50) | 0.07 |
Vomiting: yes, n (%) | 43 (20) | 7 (21) | 19 (22) | 17 (18) | 0.73 |
BMI, median (IQR) | 16 (15–18) | 15 (14–17) | 15 (14–17) | 16 (15–18) | 0.26 |
Hypoxia, median (IQR) | 99 (97–100) | 98 (97–99) | 99 (97–100) | 100 (97–100) | 0.63 |
Chest in drawing: yes, n (%) | 20 (9) | 5 (15) | 10 (12) | 5 (5) | 0.08 |
Respiratory rate, median (IQR) | 34 (31–40) | 35 (30–40) | 35 (30–40) | 34 (32–40) | 0.68 |